Skip to content

The Relaxation vs. Retreat Study

The Effect of a Short Term Meditation Retreat on Markers of Cellular Stress and Aging

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01857830
Acronym
R&R
Enrollment
96
Registered
2013-05-20
Start date
2013-04-30
Completion date
2013-07-31
Last updated
2013-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ageing, Stress, Wellbeing

Keywords

Telomerase, Telomere Length, Psychological Stress, Amyloid beta proteins, Meditation

Brief summary

The purpose of this research study is to examine whether a short term meditation intervention can improve health, mood, and biological markers of cellular stress and aging in novice and experienced meditators compared to controls.

Detailed description

There are 3 parts to this research study, Part A, B, and C. In Part A, participants complete a brief online questionnaire sent to them via email by the study coordinator. During Part B of the study, participants stay at La Costa Resort in Carlsbad, CA for 6 nights and participate in a meditation retreat being held at the resort, or stay at the resort without participating in the retreat. During their stay, participants attend two in-person research assessments throughout the week. Assessments will be 4 days (96 hours) apart for all participants and will include a fasting blood draw, body measurements, and self-report questionnaires. Part C of the study includes a brief online questionnaire that is completed 1 month after participants leave La Costa Resort. This study includes 3 groups: a group of novice meditators from the greater San Diego Region that are randomized into either the 1) Relaxation (Control) group or 2) Retreat group. The third group is comprised of self-selected experienced meditators who are already enrolled in the retreat. In total, 99 participants were recruited for this study. The Retreat group stays at La Costa Resort and attends a 6 day meditation retreat intervention as well as completes all research study assessments and questionnaires. The Relaxation (Control) group stays at La Costa Resort for 6 nights, but does not attend the meditation retreat. They attend once daily lectures on science topics and complete all research study assessments and questionnaires. The Experienced Retreat group participants have an ongoing meditation practice and have enrolled themselves in the April 2013 meditation retreat. All of the Experienced meditators attend the meditation retreat and complete all research study assessments and questionnaires.

Interventions

The intervention is a one week meditation and yoga retreat hosted at the La Costa Resort and Spa in Carlsbad, CA.

BEHAVIORALActive Comparator Relaxation Group

Participants are randomized to stay at La Costa Resort and Spa for 6 days. Participants will receive daily meals similar to the meals for those in the retreat group. Participants will also receive a daily one hour lecture on topics related to longevity and health.

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Women * Age 30-60 * Novice Meditator (meditates for 30 minutes per week or less) or Experienced Meditator (meditates at 40 or more per week and for more than 6 months, and are self-selected/enrolled in the retreat)

Exclusion criteria

* Current or history of a major medical condition (such as cancer, heart disease, autoimmune disease, diabetes) * Smokers (have not smoked regularly for the past 6 months) * Currently taking antidepressants * Post Traumatic Stress Disorder * Currently taking Hormone Replacement Therapy or birth control pills

Design outcomes

Primary

MeasureTime frameDescription
TelomeraseChange from Baseline in Telomerase 96 hours laterParticipants blood will be drawn by licensed phlebotomist on the day after their arrival at La Costa Resort at their baseline assessment and again 96 hours later at their follow-up assessment. Telomerase will be measured at both time points.

Secondary

MeasureTime frameDescription
Amyloid Beta ProteinsChange from baseline in Amyloid Beta Proteins, 96 hours laterParticipants blood will be drawn by licensed phlebotomist on the day after their arrival at La Costa Resort at their baseline assessment and again 96 hours later at their follow-up assessment. Amyloid beta protein levels will be measured in the blood at both time points.
Psychological Well beingChange from Baseline in psychological well being at 96 hours, and 1 month later.We will collect self reported measures of vitality, purpose in life, perceived stress, rumination, self-compassion, mindfulness, presence in the moment, mind wandering, depression, acceptance and action, and body responsiveness in questionnaires. Participants complete questionnaires before arriving at La Costa (baseline), after their stay (follow-up) and one month after they leave (1-month follow-up). Additionally, they complete daily questionnaires that ask about their daily experiences (emotions, stress).
OxytocinChange from baseline in Oxytocin at 96 hours later.Plasma is saved from baseline and 96 hour followup for oxytocin assays.
Telomere LengthChange from Baseline in Telomere Length, 96 hours laterParticipants blood will be drawn by licensed phlebotomist on the day after their arrival at La Costa Resort at their baseline assessment and again 96 hours later at their follow-up assessment. Telomere Length will be measured at both time points.
Gene ExpressionChange from Baseline in Gene Expression, 96 hours laterParticipants blood will be drawn by licensed phlebotomist on the day after their arrival at La Costa Resort at their baseline assessment and again 96 hours later at their follow-up assessment. Patterns of gene expression (specifically on genes related to aging) will be measured at both time points.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026